Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.

作者: Katherine M. Harrington , Charles V. Clevenger

DOI: 10.1074/JBC.M116.726190

关键词:

摘要: Accumulating evidence supports a role for prolactin (PRL) in the development and progression of human breast cancer. Although PRL is an established chemoattractant cancer cells, precise molecular mechanisms how regulates cell motility invasion are not fully understood. activates serine/threonine kinase NEK3, which was reported to enhance migration, invasion, actin cytoskeletal reorganization necessary these processes. However, specific NEK3 activation response signaling have been defined. In this report, novel PRL-inducible regulatory phosphorylation site within segment threonine 165 (Thr-165), identified. Phosphorylation at Thr-165 found be dependent on extracellular signal-regulated 1/2 (ERK1/2) pathway using both pharmacological inhibition siRNA-mediated knockdown approaches. Strikingly, by expression phospho-deficient mutant (NEK3-T165V) resulted increased focal adhesion size, formation zyxin-positive adhesions, cytoskeleton into stress fibers. Concordantly, NEK3-T165V cells exhibited migratory defects. Together, data support modulatory maturation and/or turnover promote migration.

参考文章(77)
Zlata Mujagić, Hamza Mujagić, Importance of serum prolactin determination in metastatic breast cancer patients. Croatian Medical Journal. ,vol. 45, pp. 176- 180 ,(2004)
D. M. Payne, A. J. Rossomando, P. Martino, A. K. Erickson, J. H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, T. W. Sturgill, Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). The EMBO Journal. ,vol. 10, pp. 885- 892 ,(1991) , 10.1002/J.1460-2075.1991.TB08021.X
W. L. Farrar, H. Rui, L. Dasilva, R. A. Kirken, O. M. Z. Howard, Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors Journal of Biological Chemistry. ,vol. 269, pp. 18267- 18270 ,(1994) , 10.1016/S0021-9258(17)32296-2
F.A. Gonzalez, D.L. Raden, R.J. Davis, Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. Journal of Biological Chemistry. ,vol. 266, pp. 22159- 22163 ,(1991) , 10.1016/S0021-9258(18)54548-8
Erich A. Nigg, Christine SUtterlin, Andrew M. Fry, Thomas Ried, Sharon J. Schultz, Cell cycle-dependent expression of Nek2, a novel human protein kinase related to the NIMA mitotic regulator of Aspergillus nidulans Cell Growth & Differentiation. ,vol. 5, pp. 625- 635 ,(1994)
K.P. Lu, B.E. Kemp, A.R. Means, Identification of substrate specificity determinants for the cell cycle-regulated NIMA protein kinase. Journal of Biological Chemistry. ,vol. 269, pp. 6603- 6607 ,(1994) , 10.1016/S0021-9258(17)37415-X
Christopher J. Caunt, Matthew J. Sale, Paul D. Smith, Simon J. Cook, MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road Nature Reviews Cancer. ,vol. 15, pp. 577- 592 ,(2015) , 10.1038/NRC4000